Immune protection against tuberculosis - When is immunotherapy preferable to vaccination?

Tuberculosis

Volumn 91, Issue 2, 2011, Pages 179-185

  Grange, J M ^a   Brunet, L Rosa ^a   Rieder, H L ^b,c  

^a London Clinic Cancer Centre   (United Kingdom)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bacille Calmette Gu rin (BCG); Immunotherapy; Prophylaxis; Tuberculosis; Vaccination

Indexed keywords

BCG VACCINE;

BCG VACCINATION; HISTORY OF MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TUBERCULOSIS;

ADOLESCENT; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; LATENT TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION;

EID: 79952488544     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.12.004     Document Type: Review

References (84)

1. L.V. Gardner The history of the Rl strain of tubercle bacillus Am Rev Tuberc 25 1932 577 590
2. A. Calmette, and C. Guérin Novelles recherches expérimentales sur la vaccination des bovidés contre la tuberculose Ann Inst Pasteur 34 1920 553 560
3. A. Calmette, and C. Guérin Vaccination des bovidés contre la tuberculose et méthodes nouvelles de prophylaxie de la tuberculose bovine Ann Inst Pasteur 38 1924 371 398
4. A. Calmette La Vaccination Préventive Contre la Tuberculose 1927 Masson et Cie Paris
5. C. Abou-Zeid, I. Smith, J.M. Grange, J. Steele, and G.A.W. Rook Subdivision of daughter strains of Bacille Calmette Guerin (BCG) according to secreted protein patterns J Gen Microbiol 132 1986 3047 3052
6. H.G. ten Dam BCG vaccination L.B. Reichamn, E.S. Hershfield, Tuberculosis. A comprehensive international approach 1993 Marcel Dekker New York 251 274 [Lung biology in health and disease series no. 66]
7. N.G. Fomukong, J.W. Dale, T.W. Osborn, and J.M. Grange Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains J Appl Bacteriol 72 1992 126 133
8. M.A. Behr BCG - different strains, different vaccines? Lancet Infect Dis 2 2002 86 92 (Pubitemid 36114142)
9. K. Bejartveit Olaf Scheel and Johannes Heimbeck: their contribution to understanding the pathogenesis and prevention of tuberculosis Int J Tuberc Lung Dis 7 2003 306 311
10. H.L. Rieder Die Abklärung der Lübecker Sä uglingstuberkulose (Clarification of the Luebeck infant tuberculosis) Pneumologie 57 2003 402 405 (Pubitemid 36963064)
11. G.A. Colditz, T.F. Brewer, C.S. Berkey, G.A. Colditz, T.F. Brewer, and C.S. Berkey Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 1994 698 702 (Pubitemid 24061706)
12. P.E.M. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
13. P. Anderson, and T.M. Doherty The success and failure of BCG - implications for a novel tuberculosis vaccine Nat Rev Microbiol 3 2005 656 662 (Pubitemid 41052152)
14. D. Elias, H. Akuffo, A. Pawlowski, M. Haile, T. Schön, and S. Britton Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis Vaccine 23 2005 1326 1334 (Pubitemid 40127324)
15. P.D. Hart, and I. Sutherland BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council Brit Med J 2 1977 293 295 (Pubitemid 8153940)
16. S.H. Kaufmann, G. Hussey, and P.H. Lambert New vaccines for tuberculosis Lancet 375 2010 2110 2119
17. M.P.R. Berry, C.M. Graham, and F.W. McNab An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 466 2010 973 977
18. S.R. Rosenthal Cancer precursors and their control by BCG Dev Biol Stand 58 1986 401 416 (Pubitemid 17083940)
19. A. Soysal, K.A. Millington, M. Bakir, D. Dosanjh, Y. Aslan, and J.J. Deeks Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study Lancet 366 2005 1443 1451 (Pubitemid 41483810)
20. J. Eriksen, J.Y. Chow, V. Mellis, B. Whipp, S. Walters, and E. Abrahamson Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax 65 2010 1067 1071
21. M.D. Yates, and J.M. Grange Incidence and nature of human tuberculosis due to bovine tubercle bacilli in South East England: 1977-1987 Epidemiol Infect 101 1988 225 229
22. G. Canetti Les réinfections tuberculeuses latentes du poumon. Étude anatomo-pathologique, bactériologique et pathogénique des lésions tuberculeuses abortive autres que de primo-infection 1939 Vigot Frres Paris
23. H.L. Rieder Commentary: reconciling historical, epidemiological, bacteriological and immunological observations on tuberculosis Int J Epidemiol 37 2008 932 934
24. E. Vynnycky, and P.E. Fine The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection Epidemiol Infect 119 1997 183 201 (Pubitemid 27474799)
25. C.Y. Chiang, and L.W. Riley Exogenous reinfection in tuberculosis Lancet Infect Dis 5 2005 629 636 (Pubitemid 41383908)
26. G.P. Dunn, L.J. Old, and R.D. Schreiber The three Es of cancer immunoediting Annu Rev Immunol 22 2004 329 360 (Pubitemid 38680426)
27. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu Rev Immunol 19 2001 93 129 (Pubitemid 32368031)
28. R.J. North, and Y.J. Jung Immunity to tuberculosis Annu Rev Immunol 22 2004 599 623 (Pubitemid 38680435)
29. J.L. Flynn, and J. Chan What's good for the host is good for the bug Trends Microbiol 13 2005 98 102 (Pubitemid 40311891)
30. T. Ulrichs, and S.H. Kaufmann New insights into the function of granulomas in human tuberculosis J Pathol 208 2006 261 269 (Pubitemid 43126118)
31. V. Lazarevic, D. Nolt, and J.L. Flynn Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses J Immunol 175 2005 1107 1117 (Pubitemid 41094997)
32. J.P. Scott-Browne, S. Shafiani, G. Tucker-Heard, K. Ishida-Tsubota, J.D. Fontenot, and A.Y. Rudensky Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis J Exp Med 204 2007 2159 2169 (Pubitemid 47360876)
33. L.G. Wayne In vitro model of hypoxically induced nonreplicating persistence of Mycobacterium tuberculosis Methods Mol Med 54 2001 247 269
34. J.L. Stanford Much's granules revisited Tubercle 68 1987 241 242
35. I.M. Orme The latent tubercle bacillus (I'll let you know if I ever meet one) Int J Tuberc Lung Dis 5 2001 589 593 (Pubitemid 32652148)
36. J.M. Grange The mystery of the mycobacterial persistor Tuber Lung Dis 73 1992 249 251
37. J.M. Grange Would you know one if you met one? Int J Tuberc Lung Dis 5 2001 1162 1163 (Pubitemid 34033219)
38. R. Hernández-Pando, M. Jeyanathan, G. Mengistu, D. Aguilar, H. Orozco, and M. Harboe Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection Lancet 356 2000 2133 2138
39. P.J. Cardona, and J. Ruiz-Manzano On the nature of Mycobacterium tuberculosis-latent bacilli Eur Respir J 24 2004 1044 1051 (Pubitemid 39642298)
40. G.A. Rook, K. Dheda, and A. Zumla Immune responses to tuberculosis in developing countries: implications for new vaccines Nat Rev Immunol 5 2005 661 667 (Pubitemid 41113197)
41. G.A. Rook Th2 cytokines in susceptibility to tuberculosis Curr Mol Med 7 2007 327 337 (Pubitemid 46767790)
42. P.L. Lin, and J.L. Flynn Understanding latent tuberculosis: a moving target J Immunol 185 2010 15 22
43. J.M. Grange, and A. Zumla Tuberculosis G. Cook, A. Zumla, Manson's tropical diseases 22nd ed. 2009 WB Saunders London 983 1038
44. B. Bourdin Trunz, P.E.M. Fine, and C. Dye Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness Lancet 367 2006 1173 1180
45. G.W. Comstock, and M. Merrell The life table method applied to the results of a trial of BCG vaccination in Algiers Arch Inst Pasteur Alger 36 1958 301 311
46. I. Smith Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence Clin Microbiol Rev 16 2003 463 496 (Pubitemid 36871317)
47. J.L. Stanford Immunologically important constituents of mycobacteria: antigens C. Ratledge, J.L. Stanford, The biology of the mycobacteria vol. 2 1983 Academic Press London 85 127
48. G. Kronvall, J.L. Stanford, and G.P. Walsh Studies of mycobacterial antigens, with special reference to Mycobacterium leprae Infect Immun 13 1976 1132 1138
49. J.A.K. Browne, M.M. Stone, and I. Sutherland BCG vaccination of children against leprosy in Uganda. First results Br Med J 1 1966 7 14
50. J.M. Pönnighaus, P.E. Fine, J.A. Sterne, R.J. Wilson, E. Msosa, and P.J. Gruer Efficacy of BCG vaccine against leprosy and tuberculosis in Northern Malawi Lancet 339 1992 636 639
51. Karonga Prevention Trial Group Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi Lancet 348 1996 17 24
52. F. Portaels, J. Aguiar, M. Debacker, A. Guédénon, C. Steunou, and C. Zinsou Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease Infect Immun 72 2004 62 65 (Pubitemid 38018161)
53. V. Romanus Swedish experiences 12 years after the cessation of general BCG vaccination of newborns in 1975 Bull Int Union Tuberc Lung Dis 63 4 1988 34 38 (Pubitemid 19049227)
54. L. Trnka, D. Dankova, and E. Svandova Six years' experience with the discontinuation of BCG vaccine. 4. Protective effect of BCG vaccination against Mycobacterium avium intracellulare complex Tuber Lung Dis 75 1994 348 352 (Pubitemid 24336531)
55. J.L. Stanford, C.A. Stanford, G. Stansby, O. Bottasso, G. Bahr, and J.M. Grange The common mycobacterial antigens and their importance in the treatment of disease Curr Pharm Des 15 2009 1248 1260
56. V. Schauf, W.N. Rom, K.A. Smith, E.P. Sampaio, P.A. Meyn, and J.M. Tramontana Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients J Infect Dis 168 1993 1056 1059 (Pubitemid 23282590)
57. R. Hernandez-Pando, and G.A.W. Rook The role of TNFα in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance Immunology 82 1994 591 595
58. H.-M. Surcel, M. Troyer-Blomberg, S. Paulie, G. Andersson, C. Moreno, and G. Pasvol Th1/Th2 profiles in tuberculosis based on proliferation and cytokine response of blood lymphocytes to mycobacterial antigens Immunology 81 1994 171 176 (Pubitemid 24223189)
59. G.A. Rook, G. Seah, and A. Ustianowski M. tuberculosis: immunology and vaccination Eur Respir J 17 2001 537 557 (Pubitemid 32600625)
60. J.M. Grange, O. Bottasso, C.A. Stanford, and J.L. Stanford The use of mycobacterial adjuvant-based agents for immunotherapy of cancer Vaccine 26 2008 4084 4090
61. M.L. Garly, C.L. Martins, C. Balé, M.A. Baldé, K.L. Hedegaard, and P. Gustafson BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 21 2003 2782 2790 (Pubitemid 36705530)
62. M.L. Garly, C. Balé, C.L. Martins, M.A. Baldé, K.L. Hedegaard, and H.C. Whittle BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens Vaccine 20 2001 468 474 (Pubitemid 32973790)
63. M.O. Ota, J. Vekemans, S.E. Schlegel-Haueter, K. Fielding, M. Sanneh, and M. Kidd Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination J Immunol 168 2002 919 925 (Pubitemid 34049596)
64. R.N. Ushijima, and C.L. Larson BCG prevents recurrent herpes genitalis infection J Am Med Assoc 225 1973 466 467
65. M.L. Barreto, L.C. Rodrigues, P.C. Silva, A.M. Assis, M.G. Reis, and C.A. Santos Lower hookworm incidence, prevalence and intensity of infection in children with a Bacillus Calmette-Guérin scar J Infect Dis 182 2000 1800 1803
66. J.M. Grange, and J.L. Stanford BCG vaccination and cancer Tubercle 71 1990 61 64 (Pubitemid 20095027)
67. A. Pfahlberg, K.F. Kölmel, J.M. Grange, G. Mastrangelo, B. Krone, and I.N. Botev Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study J Invest Dermatol 119 2002 570 575
68. B. Krone, K.F. Kölmel, J.M. Grange, G. Mastrangelo, B.M. Henz, and I.N. Botev Impact of vaccinations and infectious diseases on melanoma risk - evaluation of an EORTC case-control study Eur J Cancer 39 2003 2372 2378 (Pubitemid 37214862)
69. K.F. Kölmel, J.M. Grange, B. Krone, G. Mastrangelo, C.R. Rossi, and B.M. Henz Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients Eur J Cancer 41 2005 118 125 (Pubitemid 40029664)
70. T. Corrah, P. Byass, S. Jaffar, V. Thomas, V. Bouchier, and J.L. Stanford Prior BCG vaccination improves survival of Gambian patients treated for pulmonary tuberculosis Trop Med Int Health 5 2000 413 417 (Pubitemid 30469975)
71. K. Jeremiah, G. Praygod, D. Faurholt-Jepsen, N. Range, A.B. Andersen, and H.M. Grewal BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine? Thorax 65 2010 1072 1076
72. J.L. Stanford, C.A. Stanford, and J.M. Grange Environmental echoes Sci Prog 84 Part 2 2001 105 124
73. F. Guarner, R. Bourdet-Sicard, P. Brandtzaeg, H.S. Gill, P. McGuirk, and W. van Eden Mechanisms of disease: the hygiene hypothesis revisited Nat Clin Pract Gastroenterol Hepatol 3 2006 275 284 (Pubitemid 43675024)
74. A. Marchant, T. Goetghebuer, M.O. Ota, I. Wolfe, S.J. Ceesay, and D. De Groote Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination J Immunol 163 1999 2249 2255 (Pubitemid 29382234)
75. G.A. Colditz, C.S. Berkey, F. Mosteller, T.F. Brewer, M.E. Wilson, and E. Burdick The efficacy of Bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature Pediatrics 96 1995 29 35
76. J.L. Stanford, M.J. Shield, and G.A.W. Rook How environmental mycobacteria may predetermine the protective efficacy of BCG Tubercle 62 1981 55 62 (Pubitemid 11177250)
77. A.S. Pym, P. Brodin, R. Brosch, M. Huerre, and S.T. Cole Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti Mol Microbiol 46 2002 709 717 (Pubitemid 35365606)
78. D. Dlugovitzky, G. Fiorenza, M. Farroni, C. Bogue, C. Stanford, and J. Stanford Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis Respir Med 100 2006 1079 1087
79. L.E. Den Dooren de Jong De tuberculose van bacteriologisch stanpunt bezien Nederl Tijdscr Geneesk 83 1939 5896 5906
80. J.M. Grange Bacille Calmette-Guérin - the honorable daughter of wayward parents L.T. Smithe, Focus on tuberculosis research 2005 Nova Science Hauppauge, NY 77 120 2005
81. Durban Immunotherapy Trial Group Randomised controlled trial of immunotherapy with Mycobacterium vaccae in newly diagnosed pulmonary tuberculosis patients in South Africa Lancet 354 1999 116 119
82. G. de Bruyn, and P. Garner Mycobacterium vaccae immunotherapy for treating tuberculosis Cochrane Database Syst Rev 2003 (1):CD001166
83. J.L. Johnson, R.M. Kamya, A. Okwera, A.M. Loughlin, S. Nyole, and D.L. Hom Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis J Infect Dis 181 2000 1304 1312 [The Uganda-Case Western Reserve University Research Collaboration] (Pubitemid 30252534)
84. C.F. von Reyn, L. Mtei, R.D. Arbeit, R. Waddell, B. Cole, and T. Mackenzie Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine AIDS 24 2010 675 685